Applied DNA Sciences Inc APDN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if APDN is a good fit for your portfolio.
News
-
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
-
Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
-
Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
-
Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
-
Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
Trading Information
- Previous Close Price
- $1.03
- Day Range
- $1.04–1.12
- 52-Week Range
- $0.75–1.93
- Bid/Ask
- $1.04 / $1.12
- Market Cap
- $15.16 Mil
- Volume/Avg
- 52,716 / 30,726
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.86
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (“DNA”). The company operates in three business segments- the manufacture of synthetic DNA for use in nucleic acid-based therapeutics, the detection of DNA in molecular diagnostics; testing services, the manufacture and detection of DNA for industrial supply chain security services. The company provides its products and services under the brand of Applied DNA Sciences®, SigNature® molecular tags, SigNature® T molecular tags, fiberTyping®, SigNify® and others. Geographically, revenue is derived from Americas.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 69
- Website
- https://www.adnas.com
Valuation
|
Metric
|
APDN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.98 |
Price/Sales | 0.86 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
APDN
|
|---|---|
Quick Ratio | 3.96 |
Current Ratio | 4.23 |
Interest Coverage | — |
Quick Ratio
APDN
Profitability
|
Metric
|
APDN
|
|---|---|
Return on Assets (Normalized) | −63.25% |
Return on Equity (Normalized) | −122.64% |
Return on Invested Capital (Normalized) | −116.17% |
Return on Assets
APDN
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Lyj | $190.8 Bil | |
DHR
| Danaher Corp | Hvndpd | $163.1 Bil | |
IDXX
| IDEXX Laboratories Inc | Kkkhzn | $43.3 Bil | |
IQV
| IQVIA Holdings Inc | Twfzn | $39.3 Bil | |
A
| Agilent Technologies Inc | Cpmmv | $37.7 Bil | |
MTD
| Mettler-Toledo International Inc | Sdqjzy | $23.7 Bil | |
ICLR
| Icon PLC | Gcmdb | $22.2 Bil | |
LH
| Laboratory Corp of America Holdings | Nyfjhv | $18.5 Bil | |
ILMN
| Illumina Inc | Yxtwwp | $18.1 Bil | |
WAT
| Waters Corp | Xwb | $17.1 Bil |